The ImClone Alumni: Where Are They Now?

Jeff Brodsky, senior director, human resources, NPS Pharmaceuticals

Kathryn Burkhardt, associate director, office services, ImClone Systems, a subsidiary of Eli Lilly

Joe Cacciatore, executive director, ethics & compliance, Novartis

Nick Campbell, biotechnology consultant and public speaker

David Carroll, director of application development, ImClone Systems, a subsidiary of Eli Lilly

Fred Charran, director of global forecasting, business analytics and competitive intelligence, ImClone Systems, a subsidiary of Eli Lilly

Eugene Piatnitski Chekler, senior research scientist, Pfizer

Edward Conard, technical training manager, ImClone Systems, a subsidiary of Eli Lilly

Joan Connolly, AVP, clinical supply and logistics, ImClone Systems, a subsidiary of Eli Lilly

Robert Crotty, senior counsel, NPS Pharmaceuticals

Rick Crowley, senior vice president of operations, ImClone Systems, a subsidiary of Eli Lilly

Joseph D’Amore, principal, The D’Amore Group

Edward Daniel, CEO, D&D Consulting

Darius Darabian, QC supervisor, Pfizer

Kim Daves, biotechnology professional

David Dawson, associate vice president, medical affairs, ImClone Systems, a subsidiary of Eli Lilly

Alex Denner, managing director, Icahn Partners

Bill Dlouhy, vice president of product planning/logistics, ImClone Systems, a subsidiary of Eli Lilly

Jacqueline Doody, principal scientist, ImClone Systems, a subsidiary of Eli Lilly

Jason Dow, associate director of quality systems, ImClone Systems, a subsidiary of Eli Lilly

Michael Dowd, associate vice president of project and portfolio management, ImClone Systems, a subsidiary of Eli Lilly

Jason Ellison, manager of regulatory operations, Vertex Pharmaceuticals

Annette Ervin-Haynes, executive director of clinical R&D oncology, Celgene

Susan Fairman, vice president of human resources, SL Technologies

Deborah Faust, vice president of strategic growth and development, Meniscus Limited

Peggy Ference, northeast regional sales director, Dendreon

Kimberley Gee-Ritchie, QC scientist, Pfizer

Michael Golembiewski, corporate controller, NPS Pharmaceuticals

Ron Greig, associate director of development operations, global clinical sciences, ImClone Systems, a subsidiary of Eli Lilly

Bob Guglielmon, e-learning manager, ImClone Systems, a subsidiary of Eli Lilly

Terry Gwaltney, genomic national accounts manager, Genomic Health

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.